Drug discovery: past, present and future

Drug Discovery Today

Volumn 13, Issue 21-22, 2008, Pages 909-912

  Malik, Nafees N ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GENERIC DRUG; NEW DRUG; ROFECOXIB; ROSIGLITAZONE;

BIOTECHNOLOGY; COMPETITION; COST BENEFIT ANALYSIS; DRUG APPROVAL; DRUG COST; DRUG DISCOVERY; DRUG EFFICACY; DRUG INDUSTRY; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; FUTUROLOGY; GENETIC PREDISPOSITION; GOVERNMENT; HEALTH CARE COST; HISTORY; ISOMER; LIFE EXPECTANCY; METABOLITE; PATENT; PHARMACOGENOMICS;

ANIMALS; BIOLOGICAL PRODUCTS; BIOPHARMACEUTICS; BIOTECHNOLOGY; DRUG INDUSTRY; DRUG THERAPY; HUMANS; PHARMACOGENETICS;

EID: 54049101216     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2008.09.007     Document Type: Editorial

References (21)

1. Arias, E. (2006) United States Life Tables, 2003. National Vital Statistics Reports 54, No. 14, 1-40. Available at URL: http://www.cdc.gov/nchs/data/nvsr/nvsr54/nvsr54_14.pdf
2. Pollack, A. (2002) Despite Billions for Discoveries, Pipeline of Drugs Is Far From Full. The New York Times April 19. Available at URL: http://query.nytimes.com/gst/fullpage.html?res=9407E4DB153FF93AA25757C0A9649C8B63
3. Pharmaceutical Research and Manufacturers of America. Pharmaceutical Industry Profile 2008. Washington DC, USA: Pharmaceutical Research and Manufacturers of America, March 2008. Available at URL: http://www.phrma.org/files/2008%20Profile.pdf
4. IMS Health. Intelligence.360-Global Pharmaceutical Perspectives 2007. Norwalk, CT, USA: IMS Health 2008. Available at URL: http://www.imshealth.com/portal/site/imshealth/menuitem.c96f97d74b76899c33a004f09418c22a/?vgnextoid=b04e51dd68585110VgnVCM10000071812ca2RCRD&vgnextfmt=default
5. IMS Health. IMS Health Reports U.S. Prescription Sales Grew 3.8 Percent in 2007, to $286.5 Billion [press release]. IMS Health 2008 March 12. Available at URL: http://www.imshealth.com/portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=280c1d3be7a29110VgnVCM10000071812ca2RCRD&vgnextfmt=default
6. IMS Health. IMS 2008 Global Pharmaceutical Market Forecast [press release]. IMS Health 2007 December 6. Available at URL: http://www.imshealth.com/web/content/0,3148,64576068_63872702_70260998_82829532,00.html
7. Saigol, L. (2008) A painful prognosis for big drugmakers. Financial Times May 8. Available at URL: http://www.ft.com/home/uk
8. Pfizer. Pfizer Inc. 2007 Financial Report. New York, NY, USA: Pfizer, 2008. Available at URL: http://media.pfizer.com/files/annualreport/2007/financial/financial2007.pdf
9. Arnst, C. (2008) Big Pharma's Patent Headache. BusinessWeek February 6. Available at URL: http://www.businessweek.com/bwdaily/dnflash/content/feb2008/db2008025_791527.htm?campaign_id=rss_daily
10. IMS Health. Top Ten Companies by U.S. Sales [press release]. IMS Health March 2007. Available at URL: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Document/Top-Line%20Industry%20Data/2006%20Top%2010%20Companies%20by%20US%20Sales.pdf
11. Hughes B. 2007 FDA drug approvals: a year of flux. Nat. Rev. Drug Discov. 7 (2008) 107-109. http://www.nature.com/nrd/journal/v7/n2/full/nrd2514.html 10.1038/nrd2514 Available at URL: http://www.nature.com/nrd/journal/v7/n2/full/nrd2514.html
12. Whalen J. Overseas Drugs Hit U.S. Regulatory Snag. Wall St. J. (2008 March 26). http://online.wsj.com/article/SB120648160360663519.html%3Fmod=dist_smartbrief Available at URL: http://online.wsj.com/article/SB120648160360663519.html?mod=dist_smartbrief
13. Frank R.G. Prescription-Drug Prices. N. Engl. J. Med. 351 (2004) 1375-1377. http://content.nejm.org/cgi/content/full/351/14/1375%23R2 Available at URL: http://content.nejm.org/cgi/content/full/351/14/1375#R2
14. Kaiser Family Foundation. Kaiser Slides: Medicare [online]. Available at URL: http://facts.kff.org/results.aspx?view=slides&topic=2
15. Simons J. Big Pharma's tough medicine. Fortune (2007 December 13). http://money.cnn.com/2007/12/10/news/companies/pharma_layoffs.fortune/index.htm%3Fpostversion=2007121311 Available at URL: http://money.cnn.com/2007/12/10/news/companies/pharma_layoffs.fortune/index.htm?postversion=2007121311.
16. IMS Health. IMS Health Reports Global Biotech Sales Grew 12.5 Percent in 2007, Exceeding $75 Billion [press release]. IMS Health 2008 June 17. Available at URL: http://www.imshealth.com/portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=bba69e392879a110VgnVCM100000ed152ca2RCRD&vgnextfmt=default
17. Lorenzo A. Biotech as Bush bows out. Nat. Biotechnol. 26 (2008) 15-18. http://www.nature.com/nbt/journal/v26/n1/full/nbt0108-15.html 10.1038/nbt0108-15 Available at URL: http://www.nature.com/nbt/journal/v26/n1/full/nbt0108-15.html
18. Moran N. Fractured European market undermines biosimilar launches. Nat. Biotechnol. 26 (2008) 5-6. http://www.nature.com/nbt/journal/v26/n1/full/nbt0108-5.html 10.1038/nbt0108-5 Available at URL: http://www.nature.com/nbt/journal/v26/n1/full/nbt0108-5.html
19. Genomics and Personalized Medicine Act of 2006, S. 3822, 109th Congress, 2nd session (2006). Available at URL: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&docid=f:s3822is.txt.pdf
20. Genetic Information Nondiscrimination Act of 2008, H.R. 493, 110th Congress, 2nd session (2008). Available at URL: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110_cong_bills&docid=f:h493enr.txt.pdf
21. Hudson K.L., et al. Keeping pace with the times-The Genetic Information Nondiscrimination Act of 2008. N. Engl. J. Med. 358 (2008) 2661-2663. http://content.nejm.org/cgi/content/full/358/25/2661 Available at URL: http://content.nejm.org/cgi/content/full/358/25/2661